Swiss National Bank reduced its holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 5.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,420,592 shares of the pharmacy operator’s stock after selling 146,100 shares during the quarter. Swiss National Bank’s holdings in Walgreens Boots Alliance were worth $142,718,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also bought and sold shares of the company. American International Group Inc. increased its stake in Walgreens Boots Alliance by 781.9% in the 4th quarter. American International Group Inc. now owns 5,511,875 shares of the pharmacy operator’s stock valued at $324,980,000 after purchasing an additional 4,886,896 shares in the last quarter. Assenagon Asset Management S.A. increased its stake in Walgreens Boots Alliance by 1,518.3% in the 3rd quarter. Assenagon Asset Management S.A. now owns 611,724 shares of the pharmacy operator’s stock valued at $33,834,000 after purchasing an additional 573,924 shares in the last quarter. JNE Partners LLP purchased a new position in Walgreens Boots Alliance in the 4th quarter valued at approximately $29,881,000. Cullen Capital Management LLC increased its stake in Walgreens Boots Alliance by 205.2% in the 3rd quarter. Cullen Capital Management LLC now owns 746,010 shares of the pharmacy operator’s stock valued at $41,262,000 after purchasing an additional 501,545 shares in the last quarter. Finally, Pictet Asset Management Ltd. increased its stake in Walgreens Boots Alliance by 138.5% in the 3rd quarter. Pictet Asset Management Ltd. now owns 849,084 shares of the pharmacy operator’s stock valued at $46,963,000 after purchasing an additional 493,061 shares in the last quarter. 60.38% of the stock is owned by institutional investors and hedge funds.
WBA has been the subject of several recent research reports. Bank of America reissued a “sell” rating and set a $50.00 price target on shares of Walgreens Boots Alliance in a research report on Thursday, January 2nd. Cowen dropped their price target on Walgreens Boots Alliance from $60.00 to $54.00 and set a “market perform” rating for the company in a research report on Monday. BidaskClub downgraded Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research report on Thursday, January 23rd. Mizuho reissued a “hold” rating and set a $59.00 price target on shares of Walgreens Boots Alliance in a research report on Thursday, January 9th. Finally, Pivotal Research dropped their price target on Walgreens Boots Alliance from $60.00 to $55.00 and set a “hold” rating for the company in a research report on Wednesday, October 30th. Five equities research analysts have rated the stock with a sell rating and fifteen have assigned a hold rating to the company’s stock. Walgreens Boots Alliance currently has a consensus rating of “Hold” and an average target price of $57.94.
Walgreens Boots Alliance stock traded down $0.88 during mid-day trading on Thursday, hitting $53.59. 332,333 shares of the company were exchanged, compared to its average volume of 5,472,088. The company has a market capitalization of $46.94 billion, a P/E ratio of 13.16, a PEG ratio of 1.39 and a beta of 0.92. The company has a debt-to-equity ratio of 1.34, a current ratio of 0.66 and a quick ratio of 0.31. Walgreens Boots Alliance Inc has a 12-month low of $49.03 and a 12-month high of $74.94. The business’s 50 day simple moving average is $54.96 and its two-hundred day simple moving average is $55.36.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Wednesday, January 8th. The pharmacy operator reported $1.37 EPS for the quarter, missing the Zacks’ consensus estimate of $1.40 by ($0.03). The business had revenue of $34.34 billion during the quarter, compared to analysts’ expectations of $34.45 billion. Walgreens Boots Alliance had a net margin of 2.69% and a return on equity of 21.76%. Walgreens Boots Alliance’s revenue for the quarter was up 1.6% on a year-over-year basis. During the same period in the prior year, the firm earned $1.46 EPS. Equities research analysts predict that Walgreens Boots Alliance Inc will post 5.87 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 12th. Stockholders of record on Wednesday, February 19th will be given a $0.458 dividend. This represents a $1.83 dividend on an annualized basis and a dividend yield of 3.42%. The ex-dividend date is Tuesday, February 18th. Walgreens Boots Alliance’s dividend payout ratio is currently 30.55%.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Featured Article: Percentage Decliners
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.